The case illustrates a feared consequence of IRDS and consecutive high-pressure oxygenation in preterm neonates:  bronchopulmonary dysplasia (BPD).

Clinically, this young fellow recovered quite well and was discharged from hospital some weeks later. The oxygen therapy could be reduced step by step from permanent to intermittent to zero and currently his medication is an inhaled corticosteroid. His lungs, however, will most likely suffer from some irreversible parenchymal damage.